231 related articles for article (PubMed ID: 24116074)
1. Activation of STAT3 in human gastric cancer cells via interleukin (IL)-6-type cytokine signaling correlates with clinical implications.
Wang Z; Si X; Xu A; Meng X; Gao S; Qi Y; Zhu L; Li T; Li W; Dong L
PLoS One; 2013; 8(10):e75788. PubMed ID: 24116074
[TBL] [Abstract][Full Text] [Related]
2. (-)-Epigallocatechin-3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer.
Zhu BH; Chen HY; Zhan WH; Wang CY; Cai SR; Wang Z; Zhang CH; He YL
World J Gastroenterol; 2011 May; 17(18):2315-25. PubMed ID: 21633597
[TBL] [Abstract][Full Text] [Related]
3. Augmented gp130-mediated cytokine signalling accompanies human gastric cancer progression.
Jackson CB; Judd LM; Menheniott TR; Kronborg I; Dow C; Yeomans ND; Boussioutas A; Robb L; Giraud AS
J Pathol; 2007 Oct; 213(2):140-51. PubMed ID: 17724739
[TBL] [Abstract][Full Text] [Related]
4. [(-)-Epigallocatechin-3-gallate reduces vascular endothelial growth factor expression in gastric cancer cells via suppressing activity].
Zhu BH; He YL; Zhan WH; Cai SR; Wang Z; Zhang CH; Chen HY
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Aug; 14(8):631-5. PubMed ID: 21866460
[TBL] [Abstract][Full Text] [Related]
5. IL-17 promotes tumor angiogenesis through Stat3 pathway mediated upregulation of VEGF in gastric cancer.
Wu X; Yang T; Liu X; Guo JN; Xie T; Ding Y; Lin M; Yang H
Tumour Biol; 2016 Apr; 37(4):5493-501. PubMed ID: 26566627
[TBL] [Abstract][Full Text] [Related]
6. [Constitutive activation and clinical significance of Stat3 in human gastric cancer tissues and cell lines].
Yu LF; Zhu YB; Qiao MM; Zhong J; Tu SP; Wu YL
Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2064-9. PubMed ID: 15730617
[TBL] [Abstract][Full Text] [Related]
7. The nuclear factor-κB correlates with increased expression of interleukin-6 and promotes progression of gastric carcinoma.
Yin Y; Si X; Gao Y; Gao L; Wang J
Oncol Rep; 2013 Jan; 29(1):34-8. PubMed ID: 23117246
[TBL] [Abstract][Full Text] [Related]
8. [Gastric cancer-derived mesenchymal stem cells regulate the M2 polarization of macrophages within gastric cancer microenvironment via JAK2/STAT3 signaling pathway].
Li W; Zhao SL; Zheng P; Shi PQ; Zhou Y; Zhang T; Huo J; Yang J
Zhonghua Zhong Liu Za Zhi; 2022 Jul; 44(7):728-736. PubMed ID: 35880339
[No Abstract] [Full Text] [Related]
9. Regulation of CD44v6 expression in gastric carcinoma by the IL-6/STAT3 signaling pathway and its clinical significance.
Xu YY; Guo M; Yang LQ; Zhou F; Yu C; Wang A; Pang TH; Wu HY; Zou XP; Zhang WJ; Wang L; Xu GF; Huang Q
Oncotarget; 2017 Jul; 8(28):45848-45861. PubMed ID: 28507278
[TBL] [Abstract][Full Text] [Related]
10. IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway.
Wu X; Tao P; Zhou Q; Li J; Yu Z; Wang X; Li J; Li C; Yan M; Zhu Z; Liu B; Su L
Oncotarget; 2017 Mar; 8(13):20741-20750. PubMed ID: 28186964
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2-dependent activation of signal transducer and activator of transcription 3 by interleukin-6 in non-small cell lung cancer.
Dalwadi H; Krysan K; Heuze-Vourc'h N; Dohadwala M; Elashoff D; Sharma S; Cacalano N; Lichtenstein A; Dubinett S
Clin Cancer Res; 2005 Nov; 11(21):7674-82. PubMed ID: 16278387
[TBL] [Abstract][Full Text] [Related]
12. Astragalus extract inhibits proliferation but enhances apoptosis in gastric cancer.
Wang Z; Dong L; Zhen Y; Wang Y; Qi D; Xu A; Meng X; Li W
Pak J Pharm Sci; 2016 Sep; 29(5):1473-1482. PubMed ID: 27731799
[TBL] [Abstract][Full Text] [Related]
13. Differentially localized survivin and STAT3 as markers of gastric cancer progression: Association with Helicobacter pylori.
Pandey A; Tripathi SC; Shukla S; Mahata S; Vishnoi K; Misra SP; Misra V; Mitra S; Dwivedi M; Bharti AC
Cancer Rep (Hoboken); 2018 Jun; 1(1):e1004. PubMed ID: 32729225
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-23 promotes the migration and invasion of gastric cancer cells by inducing epithelial-to-mesenchymal transition via the STAT3 pathway.
Xu X; Yang C; Chen J; Liu J; Li P; Shi Y; Yu P
Biochem Biophys Res Commun; 2018 May; 499(2):273-278. PubMed ID: 29574157
[TBL] [Abstract][Full Text] [Related]
15. STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice.
Ernst M; Najdovska M; Grail D; Lundgren-May T; Buchert M; Tye H; Matthews VB; Armes J; Bhathal PS; Hughes NR; Marcusson EG; Karras JG; Na S; Sedgwick JD; Hertzog PJ; Jenkins BJ
J Clin Invest; 2008 May; 118(5):1727-38. PubMed ID: 18431520
[TBL] [Abstract][Full Text] [Related]
16. IL-6 mediates the signal pathway of JAK-STAT3-VEGF-C promoting growth, invasion and lymphangiogenesis in gastric cancer.
Zhao G; Zhu G; Huang Y; Zheng W; Hua J; Yang S; Zhuang J; Ye J
Oncol Rep; 2016 Mar; 35(3):1787-95. PubMed ID: 26750536
[TBL] [Abstract][Full Text] [Related]
17. Role of the IL-11/STAT3 signaling pathway in human chronic atrophic gastritis and gastric cancer.
Wang DQ; Ding XP; Yin S; Mao YD
Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173233
[TBL] [Abstract][Full Text] [Related]
18. IL-6 induces AGS gastric cancer cell invasion via activation of the c-Src/RhoA/ROCK signaling pathway.
Lin MT; Lin BR; Chang CC; Chu CY; Su HJ; Chen ST; Jeng YM; Kuo ML
Int J Cancer; 2007 Jun; 120(12):2600-8. PubMed ID: 17304514
[TBL] [Abstract][Full Text] [Related]
19. ZIPK activates the IL-6/STAT3 signaling pathway and promotes cisplatin resistance in gastric cancer cells.
Fan H; Ou Q; Su Q; Li G; Deng Z; Huang X; Bi J
FEBS Open Bio; 2021 Sep; 11(9):2655-2667. PubMed ID: 34375503
[TBL] [Abstract][Full Text] [Related]
20. CXCL1 promotes tumor growth through VEGF pathway activation and is associated with inferior survival in gastric cancer.
Wei ZW; Xia GK; Wu Y; Chen W; Xiang Z; Schwarz RE; Brekken RA; Awasthi N; He YL; Zhang CH
Cancer Lett; 2015 Apr; 359(2):335-43. PubMed ID: 25641338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
